Pharmaceutical Commerce - May/June 2011 - (Page 4)

Contents 6 Editorial Under Construction Check out these recently announced or completed projects VOL. 6, NO. 3 7 Op-Ed 14 Brand Communications New Commercial Model: Fact Vs. Fiction Belief that today’s commercial model is ‘broken’ elicits a wide range of responses from industry Fixing the Disjointed World of Marketing Operations A supply chain perspective on marketing operations can reduce cost and complexity while improving results Get Ready for EHRs as the Essential Communications Platform for Pharma Electronic health-record systems (EHRs) are bringing needed drug information to the point of care for prescribers Founder and Editor in Chief Nicholas Basta, 718 282 6112, nbasta@PharmaceuticalCommerce.com Contributing Editors Lena Anthony, Mike Faden, F.J. Quinn, Suzanne Shelley 17 Supply Chain / Logistics M ki Pa Making Pal Pallets a Supply Chain Asset Instead of a Unrecoverable Cost f an Recent pro product contamination incidents are highlighting od the import importance of having reliably clean pallets for ta warehousing and shipping warehousi in Biopharma Cold Chain Logistics Market Is On its Way to Biopharma $6 Billion Globally $ Pharmaceutical Commerce’s updated Biopharma P Ph Sourcebook estimates a 2009 market of $5.9 S So billion, heading to $6.9 billion in 2012 b bi DSC Logistics Creates a Health Care D Strategy Board S BDI Pharma Adds Reimbursement Resources to Its Specialty Distribution Service t Reverse-Logistics Provider Integrates New Software to Manage Recall Process Former CEO of Patheon Inc. Takes Over at Clinical Logistics Provider Marken 8 Top News IMS Institute calculates a $307.4B US market in 2010; forecasts a $1.1T global market by 2015 15 Generics claim 78% of f US market; prescriptions on ns dispensed were up slightly, but ightly, doctor visits declined in 2010 n Novartis, Somaxon Pharma and ha arma Catalent win 2010 Compliance om mpliance Packages of the Year a r awards Annual competition hig highlights ghlights the value of unit-dose packaging in medication adherence Google prepares for a possible $500-million penalty for illegal online pharmacy advertising, says WSJ Dispute with US DoJ highlights role of NABP’s Verified Internet Pharmacy Practice Sites (VIPPS) program Quintiles survey finds ‘value in healthcare’ to have different meanings among stakeholders Cost dominates the payer and physician perspective, manufacturers look to outcomes, while patients see little value in outcomes Editorial Board Jeffrey Berkowitz, Walgreens Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Rich Minoff, 1 Global Partners Mark Seitz, Eli Lilly & Co. Robert Zachow, Bracco Diagnostics Advertising Sales Senior Vice President and Publisher Clifford P. Tallman, Jr., 203 831 0771 ctallman@pharmaceuticalcommerce.com New England Vince Cavaseno, 617 232 2000, vcavaseno@PharmaceuticalCommerce.com Midwest David Gerchen, 314 878 3939, dgerchen@PharmacueticalCommerce.com Southeast Cathy Williams, 703 587 7142, cwilliams@PharmaceuticalCommerce.com West Richard Ayer, 949 366 9089, rayer@PharmaceuticalCommerce.com Advertising Production Natalie Willis, 615 690 3424 nwillis@pharmaceuticalcommerce.com 21 Information Technology Sales Force Automation’s Latest Kick: Mobile and Touch-Display Applications A pronounced fascination with Apple Computer’s iPad is focusing sales-IT efforts on mobility and data access; meanwhile, online e-detailing offerings win more acceptance Circulation, Reprints and Administration Senior Vice President and General Manager David Soskin, 203 831 0711 dsoskin@pharmaceuticalcommerce.com 11 Business / Finance 2011 Site Selection Report: For a Lucky Few, Biopharma Expansion a Reality Again Healthcare Commerce Media Corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp. 85 Westminster Rd., Brooklyn, NY 11218. 26 Legal/ Regulatory How REMS Affect Pharmaceutical Distribution Processes and Partners First-ever study of the impact of REMS on supply chains finds that collaboration is a critical requirement Editorial/Advertising Queries: 718 282 6112, or info@PharmaceuticalCommerce.com. Copyright 2011. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 151 Fairchild Avenue, Plainview, NY 11808-1709, tel: 800 437 7456. Fax: 516 908 3802 The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce. www.PharmaceuticalCommerce.com 27 Executive Development What Makes a Pharmaceutical Industry Leader? Personality assessments identify the traits that enable some pharma researchers to ascend to leadership roles in industry 31 Meetings and Editorial Index 4 May | June 2011 www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - May/June 2011

Pharmaceutical Commerce - May/June 2011
Table of Contents
Editorial
Op-Ed
Top News
Business / Finance
Brand Communications
Supply Chain / Logistics
Information Technology
Legal/ Regulatory
Executive Development
Meetings and Editorial Index

Pharmaceutical Commerce - May/June 2011

https://www.nxtbook.com/nxtbooks/pharmcomm/202006
https://www.nxtbook.com/nxtbooks/pharmcomm/202003
https://www.nxtbook.com/nxtbooks/pharmcomm/201911
https://www.nxtbook.com/nxtbooks/pharmcomm/201909
https://www.nxtbook.com/nxtbooks/pharmcomm/201906
https://www.nxtbook.com/nxtbooks/pharmcomm/201903
https://www.nxtbook.com/nxtbooks/pharmcomm/201811
https://www.nxtbook.com/nxtbooks/pharmcomm/201809
https://www.nxtbook.com/nxtbooks/pharmcomm/201806
https://www.nxtbook.com/nxtbooks/pharmcomm/20180304
https://www.nxtbook.com/nxtbooks/pharmcomm/20171112
https://www.nxtbook.com/nxtbooks/pharmcomm/20170910
https://www.nxtbook.com/nxtbooks/pharmcomm/20170708
https://www.nxtbook.com/nxtbooks/pharmcomm/20170506
https://www.nxtbook.com/nxtbooks/pharmcomm/20170304
https://www.nxtbook.com/nxtbooks/pharmcomm/20170102
https://www.nxtbook.com/nxtbooks/pharmcomm/20161112
https://www.nxtbook.com/nxtbooks/pharmcomm/20160910
https://www.nxtbook.com/nxtbooks/pharmcomm/20160708
https://www.nxtbook.com/nxtbooks/pharmcomm/20160506
https://www.nxtbook.com/nxtbooks/pharmcomm/20160304
https://www.nxtbook.com/nxtbooks/pharmcomm/20160102
https://www.nxtbook.com/nxtbooks/pharmcomm/20151112
https://www.nxtbook.com/nxtbooks/pharmcomm/20150910
https://www.nxtbook.com/nxtbooks/pharmcomm/20150708
https://www.nxtbook.com/nxtbooks/pharmcomm/20150506
https://www.nxtbook.com/nxtbooks/pharmcomm/20150304
https://www.nxtbook.com/nxtbooks/pharmcomm/20150102
https://www.nxtbook.com/nxtbooks/pharmcomm/20141112
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
https://www.nxtbook.com/nxtbooks/pharmcomm/20140910
https://www.nxtbook.com/nxtbooks/pharmcomm/20140708
https://www.nxtbook.com/nxtbooks/pharmcomm/20140506
https://www.nxtbook.com/nxtbooks/pharmcomm/20140304
https://www.nxtbook.com/nxtbooks/pharmcomm/20140102
https://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
https://www.nxtbook.com/nxtbooks/pharmcomm/20131112
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910
https://www.nxtbook.com/nxtbooks/pharmcomm/20130708
https://www.nxtbook.com/nxtbooks/pharmcomm/20130506
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
https://www.nxtbook.com/nxtbooks/pharmcomm/20130304
https://www.nxtbook.com/nxtbooks/pharmcomm/20130102
https://www.nxtbook.com/nxtbooks/pharmcomm/20121112
https://www.nxtbook.com/nxtbooks/pharmcomm/20120910
https://www.nxtbook.com/nxtbooks/pharmcomm/20120708
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
https://www.nxtbook.com/nxtbooks/pharmcomm/20120304
https://www.nxtbook.com/nxtbooks/pharmcomm/20120102
https://www.nxtbook.com/nxtbooks/pharmcomm/20111112
https://www.nxtbook.com/nxtbooks/pharmcomm/20110910
https://www.nxtbook.com/nxtbooks/pharmcomm/20110708
https://www.nxtbook.com/nxtbooks/pharmcomm/20110506
https://www.nxtbook.com/nxtbooks/pharmcomm/20110304
https://www.nxtbook.com/nxtbooks/pharmcomm/20110102
https://www.nxtbook.com/nxtbooks/pharmcomm/20101112
https://www.nxtbook.com/nxtbooks/pharmcomm/20100910
https://www.nxtbook.com/nxtbooks/pharmcomm/20100708
https://www.nxtbook.com/nxtbooks/pharmcomm/20100506
https://www.nxtbook.com/nxtbooks/pharmcomm/201004
https://www.nxtbook.com/nxtbooks/pharmcomm/201003
https://www.nxtbook.com/nxtbooks/pharmcomm/20100102
https://www.nxtbook.com/nxtbooks/pharmcomm/20091112
https://www.nxtbookmedia.com